CMS On the Pulse episode #9: A focus on compulsory licensing for pharmaceutical companies


The Global Life Sciences & Healthcare Sector Group is delighted to release the latest episode in its video/podcast series, On the Pulse.

The series brings together CMS lawyers and experts to discuss key industry topics impacting, innovating and disrupting the life sciences & healthcare sector.

In Episode #9 – Compulsory Licensing, Nick Beckett talks with Jonathan Chu, Sheena Jacob and Thomas Hirse.

In this episode, we discuss:

  • the rationale for compulsory licences and the requirements for granting the same
  • the rights of patent owners faced with the threat of compulsory licences
  • any requirement for patent owners to also provide know-how and technical support under a compulsory licence
  • limitations on exploitation under compulsory licences, including labelling requirements and distribution channel restrictions
  • the use of compulsory licences to deal with the supply of medical necessities during COVID-19
  • the debate regarding the need for COVID-19 vaccine patent waivers

Watch the video here or listen to the podcast here. You can also subscribe to the podcast here.

We will also be live streaming the video at the CMS LinkedIn account at 10am BST/11am CEST/1pm GST/6pm HKT on Tuesday 8 June.

For more information on compulsory licensing and the issues we have discussed, contact us or your regular CMS experts.

To watch and listen to our previous ‘On the Pulse’ episodes, visit:

  • Episode #1 - A legal roadmap for Cannabis – here
  • Episode #2 - Advertising medicines and medical devices – here
  • Episode #3 – Digital Health – Part 1 - here
  • Episode #4 – Digital Health – Part 2 - here
  • Episode #5 – Product Liability and Medical Malpractice - here
  • Episode #6 – Collaboration Disrupted: New models and players in Life Sciences collaboration – here
  • Episode #7 – Telemedicine – here
  • Episode #8 – Public Procurement - here